Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: West Pharmaceutical Services | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: West Pharmaceutical Services

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

West

4Q Revenues: $231.9 million (+18.5%)

4Q Earnings: $15 million (+20%)

FY Revenues: $913.3 million (+30%)

FY Earnings: $67 million (+45%)

Comments: The pharmaceutical systems business sales were $164 million, up 20% in the quarter. Significant product area sales gains came from prefilled syringe components, vial stopper products, and disposable syringe components and Flip-Off seals. The Tech Group sales were $70 million in the quarter, up 14%. Revenue growth was driven by $8.9 million in sales of the Exubera Inhalable Insulin device in support of Pfizer’s introduction of the product in the U.S., up from $1.1 million in 2Q2005.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters